However, various clinical trials use CCL21 gene modified dendritic cells (DCs-adenovirus CCL21) as anticancer vaccination strategies in lung cancer or melanoma (NCT00601094, NCT01433172, NCT01574222, NCT03546361 and NCT00798629). The gene discussed is CCL21; the disease is lung carcinoma.